INTERNATIONAL | U.S.
Careers
Contact Us
About us
Products
News, Press & Events
Visit this section
Visit this section
Explore our news

News & Insights

Featured story

01 September 2022

Board Announcement – Appointment of new CEO

HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.

Read more

News

LOGO

Clinical Evidence

Board Announcement – Appointment of new CEO

HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.

Read More >

LOGO

Clinical Evidence

BioMimics 3D US launch

Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly-differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up.

Read More >

LOGO

Clinical Evidence

36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live

Professor Thomas Zeller (University Heart Centre Freiburg, Bad Krozingen, Germany) today presented the 36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live.

Read More >

LOGO

Clinical Evidence

The BioMimics 3D Vascular Stent System approved in Japan

The BioMimics 3D Vascular Stent System received Shonin regulatory approval in Japan.

Read More >

LOGO

Clinical Evidence

MIMICS-2 at 1 year: 3D stent meets safety & effectiveness goals

The TCTMD reports on Timothy Sullivan's presentation at the International Symposium on Endovascular Therapy.

Read More >

LOGO

Clinical Evidence

BioMimics 3D – The Swirling Flow Stent: 4 experts share their views

Vascular news advertorial.

Read More >

LOGO

Clinical Evidence

NUI Galway will confer six leaders of the Irish medical technology sector with honorary degrees

NUI Galway will confer six outstanding leaders of the Irish medical technology (medtech) sector with honorary degrees on Monday 26 September.

Read More >

LOGO

Clinical Evidence

CX Daily news 2016 – Good day for drug-coated balloons, swirling flow stents and drug-eluting stents

Professor Peter Gaines, Sheffield,UK, made the case for why inducing swirling flow improves the outcome from endovascular procedures…

Read More >

LOGO

Clinical Evidence

Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients

PARIS, France—A “3D” helical stent that mimics the natural vascular curvature helps improve clinical symptoms and walking distance at 12 months in patients with femoropopliteal disease, according to results…

Read More >

LOGO

Clinical Evidence

Galway’s Shortcut to Global Success with its Med-Tech Startups

The city’s med tech cluster has been the springboard for a start-up which, armed with almost €30m in funding, is on the cusp of a global breakthrough.

Read More >

LOGO

Clinical Evidence

Imperial Innovations Group Plc – Uncovering the unquoted potential

Imperial Innovations has made significant progress in continuing not only to create new, exciting and innovative companies, but in nurturing existing companies towards important inflection points.

Read More >

LOGO

Clinical Evidence

Imperial Innovations Set to Increase Investment in Veryan Medical

The technology transfer, incubation and venture investment company Imperial Innovations, Veryan’s largest investor with a 44.3% shareholding, is proposing to increase its investment in the company, in order to help fund future growth…

Read More >

Discover BioMimics 3D Stent

BioMimics 3D® Vascular Stent System

The BioMimics 3D Vascular Stent System has a unique 3D helical geometry which imparts a gentle helical shape to the stented artery.

Read more
Technical information

Technical Information for the BioMimics 3D Vascular Stent System.

Read more
Clinical evidence

The MIMICS Clinical Programme: An evolving database of the safety and effectiveness of the BioMimics 3D Vascular Stent System.

Read more